Cyril De Colle

Co-Founder at Neurogastrx, Inc.

Cyril De Colle

Cyril De Colle

Co-Founder at Neurogastrx, Inc.

Biography

Founder of Neurogastrx, Inc., Cyril de Colle presently is Chief Scientific Officer at this company.

Overview
Career Highlights

Neurogastrx, Inc.

RelSci Relationships

65

Number of Boards

1

Relationships
RelSci Relationships are individuals Cyril De Colle likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at First Aid Beverages, Inc.

Relationship likelihood: Strong

Chief Executive Officer & Director at Cambridge Allergy Ltd.

Relationship likelihood: Strong

Venture Partner at OrbiMed Advisors LLC

Relationship likelihood: Strong

Partner at 5AM Venture Management LLC

Relationship likelihood: Strong

Former Senior Vice President-Business Development at Assertio Therapeutics, Inc.

Relationship likelihood: Strong

Chief Financial Officer & Senior Vice President, Finance & Corporate Development at Sunesis Pharmaceuticals, Inc.

Relationship likelihood: Strong

Venture Partner at OrbiMed Advisors LLC

Relationship likelihood: Strong

Partner at venBio Partners LLC

Relationship likelihood: Strong

President & Chief Executive Officer at Neurogastrx, Inc.

Relationship likelihood: Strong

Founder at 5AM Venture Management LLC

Relationship likelihood: Average

Paths to Cyril De Colle
Potential Connections via
Relationship Science
You
Cyril De Colle
Co-Founder at Neurogastrx, Inc.
Career History
Co-Founder
Current

Neurogastrx, Inc. operates as a venture-stage biopharmaceutical company. The firm develops biopharmaceutical products for the treatment of gastrointestinal disorders. It offers NG101, a product for the treatment of gastroparesis. The company was founded by Cyril De Colle and Pankaj Jay Pasricha and is headquartered in Campbell, CA.

Vice President
2009 - 2010

KineMed, Inc. develops and commercializes biomarker platform technology. It provides dynamic proteomics platform, a functionally interpretable systems biology platform. The company was founded by David M. Fineman and Marc K. Hellerstein in February 2001 and is headquartered in Emeryville, CA.

Sinior Clinical Scientist
2007 - 2008

Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its products include Xyrem, Erwinaze, Quadramet, Caphosol, ProstaScint, LuvoxCR and Parcopa. The firm focuses on the development and commercialization of pharmaceutical products to meet important unmet medical needs in neurology and psychiatry. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA.

Boards & Committees
Member, Board of Directors
Current

Neurogastrx, Inc. operates as a venture-stage biopharmaceutical company. The firm develops biopharmaceutical products for the treatment of gastrointestinal disorders. It offers NG101, a product for the treatment of gastroparesis. The company was founded by Cyril De Colle and Pankaj Jay Pasricha and is headquartered in Campbell, CA.

Investments
Details Hidden

Neurogastrx, Inc. operates as a venture-stage biopharmaceutical company. The firm develops biopharmaceutical products for the treatment of gastrointestinal disorders. It offers NG101, a product for the treatment of gastroparesis. The company was founded by Cyril De Colle and Pankaj Jay Pasricha and is headquartered in Campbell, CA.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Cyril De Colle. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Cyril De Colle's profile does not indicate a business or promotional relationship of any kind between RelSci and Cyril De Colle.